Perturbed hematopoietic stem and progenitor cell hierarchy in myelodysplastic syndromes patients with monosomy 7 as the sole cytogenetic abnormality.

Perturbed hematopoietic stem and progenitor cell hierarchy in myelodysplastic syndromes patients with monosomy 7 as the sole cytogenetic abnormality.

The stem and progenitor cell compartments in low and intermediate-risk myelodysplastic syndromes (MDS) have recently been described, and shown to be highly conserved when compared to those in acute myeloid leukemia (AML). Much less is known about the characteristics of the hematopoietic hierarchy of...

Bibliografske podrobnosti
Main Authors:	Dimitriou, M, Woll, P, Mortera-Blanco, T, Karimi, M, Wedge, D, Doolittle, H, Douagi, I, Papaemmanuil, E, Jacobsen, S, Hellström-Lindberg, E
Format:	Journal article
Jezik:	English
Izdano:	Impact Journals 2016

Podobne knjige/članki

Cytogenetic characteristics of hematopoietic and stromal progenitor cells in myelodysplastic syndrome
od: M A Pimenova, et al.
Izdano: (2013-07-01)

A rare case of Fanconi’s anaemia with Myelodysplastic syndrome and complex cytogenetic abnormalities-Monosomy 7 and Down’s syndrome-A case report
od: Rama H, et al.
Izdano: (2014-08-01)

Progression in patients with low- and intermediate1-risk del(5q) myelodysplastic syndromes is predicted by a limited subset of mutations.
od: Scharenberg, C, et al.
Izdano: (2016)

Myelodysplastic syndromes
od: Eva Hellström Lindberg
Izdano: (2018-06-01)

A Child with Psoriasis, Hypogammaglobulinemia, and Monosomy 7-Positive Myelodysplastic Syndrome
od: Namik Özbek, et al.
Izdano: (2015-02-01)

Progression in patients with low- and intermediate-1-risk del(5q) myelodysplastic syndromes is predicted by a limited subset of mutations
od: Christian Scharenberg, et al.
Izdano: (2017-03-01)

S162: LOSS OF HEMATOPOIETIC PROGENITORS HETEROGENEITY IS AN ADVERSE PROGNOSTIC FACTOR IN MYELODYSPLASTIC SYNDROMES
od: Charles Dussiau, et al.
Izdano: (2023-08-01)

Myelodysplastic syndromes are multiclonal diseases derived from hematopoietic stem and progenitor cells
od: Bingqing Luo, et al.
Izdano: (2022-05-01)

Cytogenetic clonal evolution In myelodysplastic syndrome
od: Aw, Eunice Ching-Yi
Izdano: (2018)

RARE CYTOGENETIC ABNORMALITIES IN MYELODYSPLASTIC SYNDROMES
od: Julie Schanz, et al.
Izdano: (2015-04-01)

Cytogenetic Abnormalities in Myelodysplastic Syndromes: An Overview
od: Mohammad Faizan Zahid, et al.
Izdano: (2016-12-01)

Constitutional SAMD9L mutations cause familial myelodysplastic syndrome and transient monosomy 7
od: Victor B. Pastor, et al.
Izdano: (2018-03-01)

Deregulated Gene Expression Pathways in Myelodysplastic Syndrome Hematopoietic Stem Cells
od: Pellagatti, A, et al.
Izdano: (2009)

Deregulated gene expression pathways in myelodysplastic syndrome hematopoietic stem cells.
od: Pellagatti, A, et al.
Izdano: (2010)

Case series: Neurocognitive assessment of three siblings with SAMD9-associated monosomy 7/myelodysplastic syndrome
od: Diana L. Cohen, et al.
Izdano: (2022-09-01)

The role and impact of Del(5q) and TP53 mutations on haematopoietic stem and progenitor cells during the progression of Myelodysplastic Syndrome to Acute Myeloid Leukaemia
od: Doolittle, H
Izdano: (2017)

CLINICAL AND CYTOGENETIC PROFILE IN PATIENTS WITH MYELODYSPLASTIC SYNDROME
od: Muneshwar Kumar, et al.
Izdano: (2019-06-01)

Cytogenetic follow-up by karyotyping and fluorescence in situ hybridization: implications for monitoring patients with myelodysplastic syndrome and deletion 5q treated with lenalidomide
od: Gudrun Göhring, et al.
Izdano: (2011-02-01)

FLT3 expression initiates in fully multipotent mouse hematopoietic progenitor cells.
od: Buza-Vidas, N, et al.
Izdano: (2011)

Identification of Prognostic Markers by Gene Expression Profiling In Myelodysplastic Syndrome Hematopoietic Stem Cells
od: Pellagatti, A, et al.
Izdano: (2010)

Myelodysplastic syndromes are propagated by rare and distinct human cancer stem cells in vivo.
od: Woll, P, et al.
Izdano: (2014)

Myelodysplastic syndromes: moving towards personalized management
od: Eva Hellström-Lindberg, et al.
Izdano: (2020-07-01)

Myelodysplastic syndromes are propagated by rare and distinct human cancer stem cells in vivo
od: Woll, P, et al.
Izdano: (2014)

Cytogenetic description of breast fibroadenomas: alterations related solely to proliferation?
od: R.R. Burbano, et al.
Izdano: (2001-08-01)

Molecular Cytogenetics Of Myelodysplastic Syndrome – Hospital Based Study
od: Isa, Asmida
Izdano: (2014)

Trisomy 14 as the only cytogenetic abnormality in myelodysplastic syndrome
od: M. N. Pautova, et al.
Izdano: (2024-09-01)

Cytogenetic features in primary myelodysplastic syndrome Egyptian patients
od: Yasser Elnahass, et al.
Izdano: (2018-03-01)

ETV6 deletion is a common additional abnormality in patients with myelodysplastic syndromes or acute myeloid leukemia and monosomy 7
od: Meaghan Wall, et al.
Izdano: (2012-12-01)

High-throughput mutational screening adds clinically important information in myelodysplastic syndromes and secondary or therapy-related acute myeloid leukemia
od: Mohsen Karimi, et al.
Izdano: (2015-06-01)

Erythroid differentiation enhances RNA mis-splicing in SF3B1-mutant myelodysplastic syndromes with ring sideroblasts
od: Moura, PL, et al.
Izdano: (2023)

IMPACT PROGNOSIS OF CYTOGENETIC ALTERATIONS IN BRAZILIAN CHILDHOOD MYELODYSPLASTIC NEOPLASM
od: Viviane Lovatel, et al.
Izdano: (2023-12-01)

Cytogenetic characteristics in Vietnamese patients diagnosed with primary myelodysplastic syndromes
od: Minh Phuong Vu, et al.
Izdano: (2022-01-01)

Cystic Hygroma and Monosomy X
od: Aykut Özek, et al.
Izdano: (2013-04-01)

Identification of gene expression-based prognostic markers in the hematopoietic stem cells of patients with myelodysplastic syndromes.
od: Pellagatti, A, et al.
Izdano: (2013)

Identification of aberrant splicing events in myelodysplastic syndrome patients with splicing factor gene mutations
od: Pellagatti, A, et al.
Izdano: (2017)

Trisomy Chromosome 6 as a Sole Cytogenetic Abnormality in Acute Myeloid Leukemia
od: Monika Gupta, et al.
Izdano: (2015-02-01)

Erratum to Myelodysplastic syndromes are propagated by rare and distinct human cancer stem cells in vivo [Cancer Cell, 25 (2014) 794-808]
od: Woll, P, et al.
Izdano: (2014)

PB1996: CYTOGENETIC FEATURES OF 164 MOROCCAN PATIENTS WITH MYELODYSPLASTIC SYNDROME
od: Yossra Aghoutane, et al.
Izdano: (2023-08-01)

Myelodysplastic Syndrome in Pakistan: Clinicohematological Characteristics, Cytogenetic Profile, and Risk Stratification
od: Rafia Mahmood, et al.
Izdano: (2018-05-01)

A case report of Monosomy 21
od: M.H Daei-Parizi, et al.
Izdano: (1999-03-01)